Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC.
Frontiers in Immunology（2024）
摘要
[This corrects the article DOI: 10.3389/fimmu.2023.1332057.].
更多查看译文
关键词
non-small cell lung cancer (NSCLC),epidermal growth factor receptor (EGFR),tyrosine kinase inhibitors (TKIs),receptor tyrosine kinases (RTKs),resistance,human EGFR3 (HER3)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要